Alpha-9 Theranostics Inc.
$344,000.00 CAD
≈ 4 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- July 1, 2021 – March 31, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q4-982291
Published purpose
This project will support the pre-clinical development of novel therapeutic radiopharmaceuticals that selectively bind to prostate-specific membrane antigen (PSMA), as potential treatments for prostate cancer.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions